Immunome Inc (IMNM)

12.73 -0.09 (-0.70%) USD  |  NASDAQ  |  Nov 05, 11:30
More

Immunome Return on Net Operating Assets

Return on Net Operating Assets Chart

View Return on Net Operating Assets for IMNM.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00

Historical Return on Net Operating Assets Data

View and export this data back to 2023. Upgrade now.
Date Value
June 30, 2024 --
March 31, 2024 --
Date Value
December 31, 2023 --

Return on Net Operating Assets Range, Past 5 Years

Upgrade
Minimum
Mar 2024
Upgrade
Maximum
Dec 2023
Upgrade
Average
Upgrade
Median
Jun 2024

Return on Net Operating Assets Benchmarks

CEL-SCI Corp --
AIM ImmunoTech Inc Upgrade
IGC Pharma Inc Upgrade
NovaBay Pharmaceuticals Inc Upgrade
Protalix BioTherapeutics Inc Upgrade

Return on Net Operating Assets Related Metrics

Return on Equity Upgrade
Return on Assets Upgrade
Return on Invested Capital Upgrade
Profit Margin (Quarterly) Upgrade
Operating Margin (Quarterly) Upgrade